The Hong Kong vision study: a pilot assessment of visual impairment in adults

M R Van Newkirk, M R Van Newkirk

Abstract

Purpose: The Hong Kong Adult Vision Pilot Study is a population based study of the distribution and determinants of eye disease in a random sample of the Chinese population age 40 and over. The present pilot study identifies the extent and causes of visual loss using methods developed in the United States and Australia. The pilot study uses the prevalence data to estimate the sample size necessary to predict the size of an effect a larger study may detect and the confidence with which that effect may be considered and the standard deviation of the Hong Kong population. The smallest detectable odds ratios were calculated based on known risk factor prevalence rates of the pilot study.

Methods: Hong Kong Chinese residents aged 40 and over in 2 random cluster sites were identified by private household census. The examinations were performed at one location and included, health history and habits, presenting and best corrected LogMar vision, Humphrey visual field and IOP measurement, dilated slit lamp, fundus examination, fundus photography and echography.

Results: In the two test sites, 355 people were examined of the 441 eligible residents (81% response). 76.6% of the population reported a change in vision in the last 10 years; 45% had not sought examination. 4.54% had vision less than 20/60. This was caused by: myopic choroidal degeneration (31%), cataract (19%), cataract + ARM (19%), ARMD (19%), glaucoma (6%), and corneal disease (6%). Vision loss increased significantly with age. Vision loss was more common in older women than in older men. The prevalence rates calculated from the pilot study data were used, requiring a relative precision of 95% and +/- 20% confidence interval of the prevalence rates, indicate that a sample size of 2500 would be a good number for a larger study.

Conclusions: The methods developed in the United States and Australia for completing eye disease prevalence studies are applicable in Hong Kong. Vision loss is increasingly common in older people and the percent of visual impairment in Hong Kong is higher than studies in the US and Australia. As the population ages demands on the health care systems will increase. The results from this pilot warrant continuation of the study. Efforts must be directed toward prevention of visual loss.

References

    1. Br J Ophthalmol. 1978 Aug;62(8):547-50
    1. JAMA. 1992 Aug 26;268(8):994-8
    1. Br J Ophthalmol. 1988 Nov;72(11):809-14
    1. Eye (Lond). 1989;3 ( Pt 4):379-84
    1. Am J Ophthalmol. 1997 Mar;123(3):328-37
    1. Ophthalmology. 1996 Nov;103(11):1721-6
    1. JAMA. 1991 Jul 17;266(3):369-74
    1. Ophthalmology. 1991 Aug;98(8):1310-5
    1. JAMA. 1992 Aug 26;268(8):989-93
    1. Invest Ophthalmol Vis Sci. 1991 Apr;32(5):1674-7
    1. Vision Res. 1995 May;35(9):1247-64
    1. Surv Ophthalmol. 1983 Nov-Dec;28(3):164-74
    1. Diabetes Res Clin Pract. 1993 Jul;21(1):67-73
    1. Invest Ophthalmol Vis Sci. 1991 Feb;32(2):422-32
    1. Ann Acad Med Singapore. 1992 Nov;21(6):785-91
    1. Trans Am Ophthalmol Soc. 1990;88:163-73; discussion 173-8
    1. Int Ophthalmol. 1990 May;14(3):135-40
    1. Am J Ophthalmol. 1981 Mar;91(3):381-95
    1. JAMA. 1993 Oct 13;270(14):1714-8
    1. Surv Ophthalmol. 1980 May-Jun;24(Suppl):335-610
    1. Br J Ophthalmol. 1936 Jun;20(6):350-60
    1. Am J Epidemiol. 1983 Aug;118(2):250-64
    1. Exp Eye Res. 1994 May;58(5):553-61
    1. Aust J Public Health. 1994 Sep;18(3):314-8
    1. Invest Ophthalmol Vis Sci. 1995 Jan;36(1):182-91
    1. Am J Epidemiol. 1991 Nov 15;134(10):1102-10
    1. Acta Ophthalmol (Copenh). 1989 Dec;67(6):609-16
    1. JAMA. 1993 Mar 10;269(10):1290-1
    1. Arch Ophthalmol. 1994 Jun;112(6):821-9
    1. Ophthalmic Epidemiol. 1994 Dec;1(3):139-48
    1. Ophthalmology. 1993 Oct;100(10):1504-12
    1. Ciba Found Symp. 1984;106:25-47
    1. Ophthalmology. 1996 Mar;103(3):357-64
    1. Am J Public Health. 1986 Feb;76(2):160-5
    1. Ann Intern Med. 1996 Jan 1;124(1 Pt 2):90-6
    1. Trans Ophthalmol Soc U K. 1985;104 ( Pt 1):1-10
    1. Br J Ophthalmol. 1989 May;73(5):365-9
    1. JAMA. 1990 Nov 14;264(18):2400-5
    1. J Am Geriatr Soc. 1995 Mar;43(3):252-5
    1. J Refract Surg. 1997 May-Jun;13(3):229-34
    1. Ophthalmology. 1994 Jun;101(6):1131-40; discussion 1140-1
    1. Surv Ophthalmol. 1995 Mar-Apr;39(5):367-74
    1. Am J Ophthalmol. 1982 Jul;94(1):91-6
    1. Trans Am Ophthalmol Soc. 1977;75:67-86
    1. Ophthalmology. 1992 Dec;99(12):1840-7
    1. Br J Ophthalmol. 1996 May;80(5):389-93
    1. Am J Ophthalmol. 1983 Oct;96(4):543-5
    1. Arch Ophthalmol. 1995 Sep;113(9):1138-43
    1. Invest Ophthalmol Vis Sci. 1996 Aug;37(9):1720-3
    1. N Engl J Med. 1988 Dec 1;319(22):1429-33
    1. Invest Ophthalmol Vis Sci. 1994 Dec;35(13):4344-7
    1. Invest Ophthalmol Vis Sci. 1993 Nov;34(12):3271-7
    1. Retina. 1992;12(2):127-33
    1. Ophthalmology. 1992 Oct;99(10):1499-504
    1. Arch Ophthalmol. 1990 Feb;108(2):286-90
    1. N Engl J Med. 1991 Nov 14;325(20):1412-7
    1. Singapore Med J. 1993 Feb;34(1):29-32

Source: PubMed

3
订阅